148 related articles for article (PubMed ID: 38742199)
1. Predictive value of bone turnover markers and thyroid indicators for bone metabolism in GD patients after treatment.
Su M; Chai J; Zheng W; Jia Q; Tan J; He Y; Zhang R; Men J; Liu W; Shi T; Ren J; Dong L; Liu L; Meng Z
Front Endocrinol (Lausanne); 2024; 15():1301213. PubMed ID: 38742199
[TBL] [Abstract][Full Text] [Related]
2. Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism.
Kumeda Y; Inaba M; Tahara H; Kurioka Y; Ishikawa T; Morii H; Nishizawa Y
J Clin Endocrinol Metab; 2000 Nov; 85(11):4157-61. PubMed ID: 11095447
[TBL] [Abstract][Full Text] [Related]
3. fT3:fT4 ratio in Graves' disease - correlation with TRAb level, goiter size and age of onset.
Minasyan M; Dulęba A; Smalarz A; Stręk M; Bryniarski P; Przybylik-Mazurek E; Hubalewska-Dydejczyk A
Folia Med Cracov; 2020 Sep; 60(2):15-27. PubMed ID: 33252592
[TBL] [Abstract][Full Text] [Related]
4. Bone turnover markers in patients with differentiated thyroid carcinoma after levothyroxine withdrawal.
Gao YC; Gu Q; Liu QP; Ge WL; Lu HK
Clin Lab; 2010; 56(3-4):87-93. PubMed ID: 20476639
[TBL] [Abstract][Full Text] [Related]
5. Eosinophil/Monocyte Ratio Combined With Serum Thyroid Hormone for Distinguishing Graves' Disease and Subacute Thyroiditis.
Hu Y; Zhou D; Chen J; Shan P
Front Endocrinol (Lausanne); 2020; 11():264. PubMed ID: 32457697
[No Abstract] [Full Text] [Related]
6. Effects of glucocorticoid pulse therapy on thyroid function and thyroid antibodies in children with graves' disease.
Hu Y; Man Y; Sun X; Xue Y
Ital J Pediatr; 2021 Mar; 47(1):46. PubMed ID: 33653401
[TBL] [Abstract][Full Text] [Related]
7. GENDER INFLUENCES THE CLINICAL PRESENTATION AND LONG-TERM OUTCOME OF GRAVES DISEASE.
Magri F; Zerbini F; Gaiti M; Capelli V; Ragni A; Rotondi M; Chiovato L
Endocr Pract; 2016 Nov; 22(11):1336-1342. PubMed ID: 27540885
[TBL] [Abstract][Full Text] [Related]
8. Triiodothyronine-predominant Graves' disease in childhood: detection and therapeutic implications.
Harvengt J; Boizeau P; Chevenne D; Zenaty D; Paulsen A; Simon D; Guilmin Crepon S; Alberti C; Carel JC; Léger J
Eur J Endocrinol; 2015 Jun; 172(6):715-23. PubMed ID: 25766047
[TBL] [Abstract][Full Text] [Related]
9. The level of TSH appeared favourable in maintaining bone mineral density in postmenopausal women.
Baqi L; Payer J; Killinger Z; Susienkova K; Jackuliak P; Cierny D; Langer P
Endocr Regul; 2010 Jan; 44(1):9-15. PubMed ID: 20151763
[TBL] [Abstract][Full Text] [Related]
10. Effects of levothyroxine therapy on bone mineral density and bone turnover markers in premenopausal women with thyroid cancer after thyroidectomy.
Bin-Hong D; Fu-Man D; Yu L; Xu-Ping W; Bing-Feng B
Endokrynol Pol; 2020; 71(1):15-20. PubMed ID: 31681976
[TBL] [Abstract][Full Text] [Related]
11. Subclinical thyroid dysfunction and circulating thyroid hormones are not associated with bone turnover markers or incident hip fracture in older men.
Siru R; Alfonso H; Chubb SAP; Golledge J; Flicker L; Yeap BB
Clin Endocrinol (Oxf); 2018 Jul; 89(1):93-99. PubMed ID: 29655173
[TBL] [Abstract][Full Text] [Related]
12. Free triiodothyronine to free thyroxine ratio in the differential diagnosis of thyrotoxicosis and hyperthyroidism: A retrospective study.
Tura Bahadır Ç; Yılmaz M; Kılıçkan E
Int J Clin Pract; 2021 May; 75(5):e14003. PubMed ID: 33403716
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of long-term follow-up and methimazole therapy outcomes of pediatric Graves' disease: a single-center experience.
Bayramoğlu E; Elmaogulları S; Sagsak E; Aycan Z
J Pediatr Endocrinol Metab; 2019 Apr; 32(4):341-346. PubMed ID: 30862763
[TBL] [Abstract][Full Text] [Related]
14. Decreased serum level of IL-7 in patients with active Graves' disease.
Motylewska E; Nieć M; Siejka A; Komorowski J; Ławnicka H; Świętosławski J; Stępień H
Cytokine; 2015 Oct; 75(2):373-9. PubMed ID: 26113403
[TBL] [Abstract][Full Text] [Related]
15. Effect of 1 alpha-hydroxyvitamin D3 on serum levels of thyroid hormones in hyperthyroid patients with untreated Graves' disease.
Kawakami-Tani T; Fukawa E; Tanaka H; Abe Y; Makino I
Metabolism; 1997 Oct; 46(10):1184-8. PubMed ID: 9322804
[TBL] [Abstract][Full Text] [Related]
16. Antithyroid therapy improves bony manifestations and bone metabolic markers in patients with Graves' thyrotoxicosis.
Nagasaka S; Sugimoto H; Nakamura T; Kusaka I; Fujisawa G; Sakuma N; Tsuboi Y; Fukuda S; Honda K; Okada K; Ishikawa S; Saito T
Clin Endocrinol (Oxf); 1997 Aug; 47(2):215-21. PubMed ID: 9302397
[TBL] [Abstract][Full Text] [Related]
17. Significance of thyroid blood flow as a predictor of methimazole sensitivity in untreated hyperthyroid patients with Graves' disease.
Nagasaki T; Inaba M; Kumeda Y; Fujiwara-Ueda M; Hiura Y; Nishizawa Y
Biomed Pharmacother; 2007 Sep; 61(8):472-6. PubMed ID: 17420111
[TBL] [Abstract][Full Text] [Related]
18. Ratio of serum free triiodothyronine to free thyroxine in Graves' hyperthyroidism and thyrotoxicosis caused by painless thyroiditis.
Yoshimura Noh J; Momotani N; Fukada S; Ito K; Miyauchi A; Amino N
Endocr J; 2005 Oct; 52(5):537-42. PubMed ID: 16284430
[TBL] [Abstract][Full Text] [Related]
19. Relationships between serum levels of thyroid hormones and serum concentrations of asymmetric dimethylarginine (ADMA) and N-terminal-pro-B-type natriuretic peptide (NT-proBNP) in patients with Graves' disease.
Gu LQ; Zhao L; Zhu W; Li FY; Zhang MJ; Liu Y; Liu JM; Ning G; Zhao YJ
Endocrine; 2011 Jun; 39(3):266-71. PubMed ID: 21387129
[TBL] [Abstract][Full Text] [Related]
20. Clinical Parameters Are More Likely to Be Associated with Thyroid Hormone Levels than with Thyrotropin Levels: A Systematic Review and Meta-Analysis.
Fitzgerald SP; Bean NG; Falhammar H; Tuke J
Thyroid; 2020 Dec; 30(12):1695-1709. PubMed ID: 32349628
[No Abstract] [Full Text] [Related]
[Next] [New Search]
